Coates, L., Garrood, T., Gullick, N., Helliwell, P., Kent, T., Marks, J., . . . McInnes, I. (2022). Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Oxford University Press.
Παραπομπή σε μορφή Chicago (17η εκδ.)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
Παραπομπή σε μορφή MLA (9th εκδ.)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.